1. Home
  2. ASYS vs SABS Comparison

ASYS vs SABS Comparison

Compare ASYS & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$17.78

Market Cap

192.4M

Sector

Technology

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$4.30

Market Cap

187.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
SABS
Founded
1981
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.4M
187.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ASYS
SABS
Price
$17.78
$4.30
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.80
AVG Volume (30 Days)
385.5K
393.4K
Earning Date
02-05-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$79,364,000.00
$114,698.00
Revenue This Year
$2.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$1.00
52 Week High
$17.44
$6.60

Technical Indicators

Market Signals
Indicator
ASYS
SABS
Relative Strength Index (RSI) 79.01 69.39
Support Level $15.93 $3.93
Resistance Level $17.44 $4.21
Average True Range (ATR) 1.01 0.28
MACD 0.19 0.03
Stochastic Oscillator 97.27 91.41

Price Performance

Historical Comparison
ASYS
SABS

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: